We were delighted to welcome Ken Macnamara, an accomplished biotech executive with deep experience spanning product development, advanced therapeutics, and company leadership, onto The BioHub!

Over the course of his career, Ken has held senior roles across innovative life sciences businesses, helping translate cutting-edge science into real-world therapies and scalable commercial platforms. He currently serves as CEO of Trogenix, where he is focused on advancing next-generation precision genetic medicines. With a background that bridges science, operations, and strategy, Ken brings a rare perspective on what it takes to build successful biotech companies in an increasingly complex healthcare landscape